Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

ClinicalTrials.gov ID: NCT05614063

Public ClinicalTrials.gov record NCT05614063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101 administered as adjunctive therapy in focal-onset seizures.

Study identification

NCT ID
NCT05614063
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Xenon Pharmaceuticals Inc.
Industry
Enrollment
380 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2022 (Actual)
Primary completion
Jan 12, 2026 (Actual)
Completion
Feb 3, 2026 (Actual)
Last update posted
May 14, 2026

2022 – 2026

United States locations

U.S. sites
56
U.S. states
28
U.S. cities
50
Facility City State ZIP Site status
Strada Patient Care Center Mobile Alabama 36604 —
Xenoscience Phoenix Arizona 85004 —
University of Arizona, Health Sciences Center Tucson Arizona 85724 —
Clinical Trials, Inc Little Rock Arkansas 72205 —
Brain Science Research Institute Los Angeles California 90025 —
University of California, David Clinical & Translational Science Center Clinical Research (CCRC) Sacramento California 95817 —
Anschutz Health Sciences Aurora Colorado 80011 —
Serenity Research Miami Florida 33176 —
Research Institute of Orlando, LLC Orlando Florida 32806 —
Panhandle Research & Medical Clinic Pensacola Florida 32503 —
Medsol Clinical Research Center Port Charlotte Florida 33952 —
University of South Florida Tampa Florida 33606 —
Encore Medical Research of Weston, LLC Weston Florida 33021 —
Emory Brain Health Center Atlanta Georgia 30329 —
Hawaii Pacific Neuroscience Honolulu Hawaii 96817 —
Consultants in Epilepsy and Neurology Boise Idaho 83702 —
Indiana University, IU Health Partners, Adult Neurology Clinic Indianapolis Indiana 46202 —
The University of Kansas Medical Center Kansas City Kansas 66160 —
Bluegrass Epilepsy Research, LLC Lexington Kentucky 40504 —
University of Kentucky, Dept. of Neurology Lexington Kentucky 40536-0284 —
MaineHealth Neurology - Scarborough Scarborough Maine 04074 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Medstar Franklin Square Medical Center Baltimore Maryland 21237 —
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817 —
MedStar Georgetown University Hospital Clinton Maryland 20735 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
UMass Memorial Medical Center Worcester Massachusetts 01655 —
University of Michigan Ann Arbor Michigan 48109 —
Michigan State University East Lansing Michigan 48824 —
Cornwell Health Grand Rapids Michigan 49506 —
Minneapolis Clinic of Neurology Burnsville Minnesota 55337 —
Saint Louis University Medical School - Neurosciences Clinical Research Unit St Louis Missouri 63104 —
Washington University, St. Louis St Louis Missouri 63110 —
Northeast Epilepsy Group Hackensack New Jersey 07601 —
Dent Neurosciences Research Center Buffalo New York 14226 —
NYU Comprehensive Epilepsy Center (CEC) New York New York 10016 —
Weill Cornell Medicine/ New York-Presbyterian Hospital New York New York 10021 —
Mount Sinai Medical Center New York New York 10029 —
SUNY Upstate Medical University Syracuse New York 13210 —
Montefiore Medical Center The Bronx New York 10467-2401 —
Onsite Clinical Solutions, LLC Charlotte North Carolina 28211 —
Duke Neurology Durham North Carolina 27713 —
Meridian Clinical Research, LLC Raleigh North Carolina 27607 —
Wake Forest Baptist Health Winston-Salem North Carolina 27157 —
Summa Health Akron Ohio 44304 —
Providence Brain & Spine Institute Portland Oregon 97225 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Temple University Hospital Philadelphia Pennsylvania 19140-4105 —
Austin Epilepsy Care Center (AECC) Austin Texas 78758 —
ANESC Research El Paso Texas 79912 —
UT Physicians Epilepsy Clinic Houston Texas 77030 —
UT Health San Antonio San Antonio Texas 78229 —
Carilion Clinic - Neurology Roanoke Virginia 24013 —
Sentara Neurology Specialists Virginia Beach Virginia 23456 —
University of Washington Main Hospital Seattle Washington 98104 —
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05614063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05614063 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →